Works by Li, Zhen Wang


Results: 87
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33080-8
    By:
    • Ju, Wu-tong;
    • Xia, Rong-hui;
    • Zhu, Dong-wang;
    • Dou, Sheng-jin;
    • Zhu, Guo-pei;
    • Dong, Min-jun;
    • Wang, Li-zhen;
    • Sun, Qi;
    • Zhao, Tong-chao;
    • Zhou, Zhi-hang;
    • Liang, Si-yuan;
    • Huang, Ying-ying;
    • Tang, Yong;
    • Wu, Si-cheng;
    • Xia, Jing;
    • Chen, Shi-qing;
    • Bai, Yue-zong;
    • Li, Jiang;
    • Zhu, Qi;
    • Zhong, Lai-ping
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50